Summary
Molecular genotyping of swine major histocompatibility complex SLA‐DQB and SLA‐DRB genes using polymerase chain reaction (PCR)‐based amplification is described. Locus‐specific oligonucleotide primers were designed for the analysis of expressed SLA genes by reverse transcription‐polymerase chain reaction (RT‐PCR). RT‐PCR products were sequenced, and the information gained was used to design primers for PCR genotyping of the exon 2 (β1) region from genomic DNA templates. A single segregating amplification product was detected for both DQB and DRB in all animals. PCR products were digested with restriction enzymes. Seven SLA‐DQB PCR‐restriction fragment length polymorphism (RFLP) pattern types were observed for both HaeIII and Rsal that defined 14 SLA‐DQB alleles. A total of seven SLA‐DRB PCR‐RFLP pattern types were defined using Mspl (3 RFLP pattern types) and Rsal (6 RFLP pattern types). In order to demonstrate their universal utility, the primers were tested on genomic DNA samples from 10 different swine breeds. No breed‐specific alleles were observed. These results show that locus‐specific oligonucleotide primers and RFLP analysis provide a simple and rapid method for genotyping expressed SLA‐DQB and SLA‐DRB from genomic DNA.
Source and description: A 0.58-kb cDNA clone pB1.4hum (ATCC #57332) encoding the 3' end of the human t complex polypeptide 1 (Willison et al. 1985) was excised as a 0.6-kb EcoRI insert from pUC9. Polymorphism: HindIII: 5.2-and 4.7-kb polymorphic fragments. and 6.3-and 2.9-kb monomorphic fragments. EcoRI: two polymorphic fragments each greater than 12kb, and 6.3-. 5.1and 2.9-kb monomorphic fragments.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.